Laboratory Co. of America Stock Forecast, Price & News

$295.86
+4.40 (+1.51 %)
(As of 09/23/2021 10:28 AM ET)
Add
Compare
Today's Range
$292.60
$296.36
50-Day Range
$274.82
$308.34
52-Week Range
$176.49
$309.60
Volume4,133 shs
Average Volume677,708 shs
Market Capitalization$28.52 billion
P/E Ratio10.10
Dividend YieldN/A
Beta1.04
30 days | 90 days | 365 days | Advanced Chart
Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratory Co. of America and its competitors with MarketBeat's FREE daily newsletter.


Laboratory Co. of America logo

About Laboratory Co. of America

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.13 out of 5 stars

Medical Sector

431st out of 1,352 stocks

Medical Laboratories Industry

12th out of 30 stocks

Analyst Opinion: 2.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Laboratory Co. of America (NYSE:LH) Frequently Asked Questions

Is Laboratory Co. of America a buy right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last year. There are currently 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Laboratory Co. of America stock.
View analyst ratings for Laboratory Co. of America
or view top-rated stocks.

What stocks does MarketBeat like better than Laboratory Co. of America?

Wall Street analysts have given Laboratory Co. of America a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Laboratory Co. of America wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Laboratory Co. of America?

Laboratory Co. of America saw a increase in short interest in the month of August. As of August 13th, there was short interest totaling 1,850,000 shares, an increase of 25.0% from the July 29th total of 1,480,000 shares. Based on an average trading volume of 687,000 shares, the short-interest ratio is currently 2.7 days. Currently, 1.9% of the company's stock are short sold.
View Laboratory Co. of America's Short Interest
.

When is Laboratory Co. of America's next earnings date?

Laboratory Co. of America is scheduled to release its next quarterly earnings announcement on Tuesday, October 26th 2021.
View our earnings forecast for Laboratory Co. of America
.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) announced its quarterly earnings results on Wednesday, July, 28th. The medical research company reported $6.13 EPS for the quarter, topping the Zacks' consensus estimate of $5.64 by $0.49. The medical research company earned $3.84 billion during the quarter, compared to the consensus estimate of $3.59 billion. Laboratory Co. of America had a net margin of 17.57% and a trailing twelve-month return on equity of 35.18%.
View Laboratory Co. of America's earnings history
.

How has Laboratory Co. of America's stock been impacted by Coronavirus (COVID-19)?

Laboratory Co. of America's stock was trading at $158.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LH shares have increased by 85.8% and is now trading at $295.40.
View which stocks have been most impacted by COVID-19
.

What guidance has Laboratory Co. of America issued on next quarter's earnings?

Laboratory Co. of America updated its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share (EPS) guidance of $21.500-$25.000 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $22.540. The company issued revenue guidance of $14.89 billion-$15.24 billion, compared to the consensus revenue estimate of $14.56 billion.

What price target have analysts set for LH?

13 brokers have issued 12 month target prices for Laboratory Co. of America's stock. Their forecasts range from $260.00 to $368.00. On average, they expect Laboratory Co. of America's stock price to reach $316.57 in the next year. This suggests a possible upside of 7.2% from the stock's current price.
View analysts' price targets for Laboratory Co. of America
or view top-rated stocks among Wall Street analysts.

Who are Laboratory Co. of America's key executives?

Laboratory Co. of America's management team includes the following people:
  • Adam H. Schechter, Chairman, President & Chief Executive Officer
  • Glenn Andrew Eisenberg, Chief Financial Officer & Executive Vice President
  • Lance V. Berberian, Chief Information & Technology Officer & EVP
  • Brian J. Caveney, Chief Medical Officer, EVP & President-Diagnostics
  • Stephen M. Anderson, Chief Scientific Officer-Covance & Senior VP

What is Adam Schechter's approval rating as Laboratory Co. of America's CEO?

143 employees have rated Laboratory Co. of America CEO Adam Schechter on Glassdoor.com. Adam Schechter has an approval rating of 73% among Laboratory Co. of America's employees.

Who are some of Laboratory Co. of America's key competitors?

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA), Abbott Laboratories (abt), AbbVie (ABBV), Alibaba Group (BABA) and Amgen (AMGN).

What is Laboratory Co. of America's stock symbol?

Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Co. of America's major shareholders?

Laboratory Co. of America's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.30%), BlackRock Inc. (8.02%), State Street Corp (4.40%), Geode Capital Management LLC (1.84%), Bank of America Corp DE (1.73%) and Bank of America Corp DE (1.73%). Company insiders that own Laboratory Co. of America stock include David P King, Der Vaart Sandra D Van, Jean-Luc Belingard, Judith C Seltz, Kerrii B Anderson, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson and R Sanders Williams.
View institutional ownership trends for Laboratory Co. of America
.

Which major investors are selling Laboratory Co. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Allen Investment Management LLC, FMR LLC, Boston Partners, Franklin Resources Inc., BlackRock Inc., Massachusetts Financial Services Co. MA, UBS Asset Management Americas Inc., and Silvercrest Asset Management Group LLC. Company insiders that have sold Laboratory Co. of America company stock in the last year include Der Vaart Sandra D Van, Jean-Luc Belingard, Mark S Schroeder, Paul R Kirchgraber, and Peter J Wilkinson.
View insider buying and selling activity for Laboratory Co. of America
or view top insider-selling stocks.

Which major investors are buying Laboratory Co. of America stock?

LH stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Amundi, State Street Corp, Eagle Asset Management Inc., Dimensional Fund Advisors LP, Renaissance Technologies LLC, Alliancebernstein L.P., and Teacher Retirement System of Texas.
View insider buying and selling activity for Laboratory Co. of America
or or view top insider-buying stocks.

How do I buy shares of Laboratory Co. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Laboratory Co. of America's stock price today?

One share of LH stock can currently be purchased for approximately $295.40.

How much money does Laboratory Co. of America make?

Laboratory Co. of America has a market capitalization of $28.48 billion and generates $13.98 billion in revenue each year. The medical research company earns $1.56 billion in net income (profit) each year or $23.94 on an earnings per share basis.

How many employees does Laboratory Co. of America have?

Laboratory Co. of America employs 72,400 workers across the globe.

Does Laboratory Co. of America have any subsidiaries?

The following companies are subsidiares of Laboratory Co. of America: 1957285 Ontario Inc. dba Quality Underwriting Services, 2089729 Ontario Inc., 2248848 Ontario Inc., 3065619 Nova Scotia Company, 3257959 Nova Scotia Company, 896988 Ontario Limited, 9279-3280 Quebec Inc., Accupath Diagnostic Laboratories Inc., Alpha Medical Laboratory LLC, Assets of Pathology Inc, Beacon LBS IPA Inc., Beacon Laboratory Benefit Solutions Inc., CannAmm GP Inc., CannAmm Limited Partnership, Center for Disease Detection International, Center for Disease Detection LLC, Centrex Clinical Laboratories Inc., Clearstone Central Laboratories (U.S.) Inc., Clearstone Holdings (International) Ltd., Clipper Holdings Inc., Colorado Coagulation Consultants Inc., Colorado Laboratory Services LLC, Correlagen Diagnostics Inc., Covance Inc., Curalab Inc., Cytometry Associates Inc., Czura Thornton (Hong Kong) Limited, DCL Acquisition Inc., DCL Medical Laboratories LLC (DE), DCL Medical Laboratories LLC (FL), DCL Sub LLC, DIANON Systems Inc., DL Holdings Limited Partnership, Decision Diagnostics L.L.C. (aka DaVinici/Medicorp LLC), Diagnostic Services Inc., DynaLifeDX, Dynacare - Gamma Laboratory Partnership, Dynacare Company, Dynacare G.P. Inc., Dynacare Holdco LLC, Dynacare Laboratories Inc., Dynacare Laboratories Limited Partnership, Dynacare Northwest Inc., Dynacare Realty Inc., DynalifeDX Infrastructure Inc., Endocrine Sciences Inc., Esoterix Genetic Counseling LLC, Esoterix Genetic Laboratories LLC, Esoterix Inc., Execmed Health Services Inc., FirstSource Laboratory Solutions Inc., GDML Medical Laboratories Inc, Gamma Dynacare Central Medical Laboratories GP Inc., Gamma Dynacare Central Medical Laboratory Limited Partnership, HHLA Lab-In-An-Envelope LLC, Health Trans Services Inc., Home Healthcare Laboratory of America LLC, IDX Pathology Inc., Impact Genetics Corp, Impact Genetics Inc., Kaleida LabCorp LLC, Lab Delivery Service of New York City Inc., LabCorp BVBA, LabCorp Belgium Holdings Inc., LabCorp Central Laboratories (Canada) Inc., LabCorp Central Laboratories (China) Inc., LabCorp Central Laboratories (Singapore) Pte., LabCorp Development Company, LabCorp Employer Services Inc., LabCorp Health System Diagnostics LLC, LabCorp Indiana Inc., LabCorp Japan G.K., LabCorp Limited, LabCorp Michigan Inc., LabCorp Nebraska Inc., LabCorp Neon Ltd., LabCorp Neon Switzerland S.à.r.l., LabCorp Specialty Testing Billing Service Inc., LabCorp Specialty Testing Group Inc., LabCorp Staffing Solutions Inc., LabCorp Tennessee LLC, LabCorp UK Holdings Ltd., LabWest Inc., Laboratoire Bio-Medic Inc., Laboratory Corporation of America, Lifecodes Corporation, LipoScience Inc., Litholink Corporation, MEDTOX Scientific Inc., Medical Neurogenitics LLC, Medtox Diagnostics Inc., Medtox Laboratories Inc., Monogram Biosciences Inc., Monogram Biosciences UK Limited, NWT Inc., National Genetics Institute, New Brighton Business Center LLC, New Imaging Diagnostics LLC, New Molecular Diagnostics Ventures LLC, Orchid Cellmark Ltd., Orchid Cellmark ULC, PA Labs Inc., Path Lab Incorporated, Pathology Associates Medical Lab LLC, Pee Dee Pathology Associates Inc., Persys Technology Inc., Pixel by LabCorp, Princeton Diagnostic Laboratories of America Inc., Protedyne Corporation, ReliaGene Technologies Inc., SW/DL LLC, Saint Josephs-PAML LLC, Sequenom Biosciences (India) Pvt. Ltd., Sequenom Center for Molecular Medicine LLC, Sequenom Inc, Sequenom Inc., Southern Idaho Regional Laboratory, Tandem Labs Inc., The LabCorp Charitable Foundation, Tri-Cities Laboratory LLC, Viro-Med Laboratories Inc., and Yakima Medical Arts Inc..

When was Laboratory Co. of America founded?

Laboratory Co. of America was founded in 1995.

What is Laboratory Co. of America's official website?

The official website for Laboratory Co. of America is www.labcorp.com.

Where are Laboratory Co. of America's headquarters?

Laboratory Co. of America is headquartered at 358 South Main Street, BURLINGTON NC, 27215.

How can I contact Laboratory Co. of America?

Laboratory Co. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at (336) 229-1127 or via email at [email protected].


This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.